| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.089 | 0.2 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |